One shot to soothe: new injection may replace eye drops after cataract surgery

NCT ID NCT06497699

Completed Disease control Sponsor: Ocumension Therapeutics (Shanghai) Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a single injection of dexamethasone (Dexycu) given during cataract surgery to control eye inflammation. Researchers compared 263 patients who received the injection to an external control group. The main goal was to see how many patients had no signs of inflammation (anterior chamber cells) 8 days after surgery. The approach aims to simplify post-surgery care by replacing multiple eye drops with one injection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dexamethasone injection (Dexycu)
What this could lead to: If successful, this could confirm a convenient single-injection option to manage post-surgery eye inflammation, reducing the need for eye drops.
What could go wrong: This is a real-world study, not a blinded trial, so results may be less reliable. Inflammation control may not be better than standard care, and side effects like increased eye pressure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT INFLAMMATION

Contacts and locations

Locations

Boao Super Hospital

Bo'ao, China
Hainan Traditional Chinese Medicine Hospital

Haikou, Hainan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.